Niraparib therapy in patients with newly diagnosed advanced ovarian cancer (PRIMA/ENGOT-OV26/GOG-3012 study)
Year: 2019
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Annals of Oncology
Authors: A. González Martín, B. Pothuri, I.B. Vergote, R.D. Christensen, W. Graybill, M.R. Mirza, C. McCormick, D. Lorusso, P. Hoskins, G. Freyer, F. Backes, K. Baumann, A. Redondo, R.G. Moore, C. Vulsteke, R.E. O’Cearbhaill, B. Lund, Y. Li, D. Gupta, B.J. Monk
Institutions: Clinica Universidad de Navarra, Spanish Ovarian Cancer Research Group, Gynecologic Oncology Group, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, New York University, University of Southern Denmark, Nordic Society of Gynecologic Oncology, Medical University of South Carolina, Copenhagen University Hospital, Rigshospitalet, BC Cancer Agency, Hôpital Lyon Sud, The Ohio State University, Klinikum Ludwigshafen, Hospital Universitario La Paz, University of Rochester Medicine, University of Rochester, University of Antwerp, AZ Maria Middelares, Memorial Sloan Kettering Cancer Center, Cornell University, Aalborg University Hospital, GlaxoSmithKline (United States), Tesaro (United States), Creighton University, University of Arizona, The US Oncology Network
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2977503682